Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05120232 · ClinicalTrials.gov registry record · NA
Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders
A NA study of Anxiety Disorders and Depressive Disorder, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT05120232: Completed NA study of Anxiety Disorders and Depressive Disorder, sponsored by Boston University Charles River Campus.
NCT05120232 is a NA study of Anxiety Disorders and Depressive Disorder that has completed, run by Boston University Charles River Campus. The registered enrollment target is 125 participants, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05120232, a NA study of Anxiety Disorders and Depressive Disorder, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
This two phase study is testing an online version of a transdiagnostic, cognitive behavioral therapy, against a modified version of that therapy emphasizing positive affect. The first phase of the trial will focus on content development for the modified therapy and the second phase will be a randomized control trial comparing the two.
Primary Outcome
This semi-structured, diagnostic clinical interview focuses on Diagnostic and Statistical Manual-5 diagnoses of anxiety disorders and their accompanying mood states, somatoform disorders, and substance and alcohol use. The information derived from the interview using the ADIS allows clinicians to determine differential diagnoses and gain a clear understanding of the level and severity of each diagnosis. Principal and additional diagnoses are assigned a clinical severity rating (CSR) on a scale f
Conditions Studied
Interventions
- BEHAVIORAL Unified Protocol
- BEHAVIORAL Modified Unified Protocol (UP+)
Study Locations (1)
Massachusetts
- Center for Anxiety and Related Disorders - Boston University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2024-01-16 |
| Phase | NA |
What the finished NCT05120232 record still lists
NCT05120232 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 2 interventions - of which Unified Protocol is the first listed.
NCT05120232 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05120232 about?
NCT05120232 is a clinical study titled "Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders". This two phase study is testing an online version of a transdiagnostic, cognitive behavioral therapy, against a modified version of that therapy emphasizing positive affect. The first phase of the trial will focus on content development for the modified therapy and the second phase will be a randomi...
What is the current status of trial NCT05120232?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2021-03-08. Estimated completion is 2024-01-16.
What conditions does trial NCT05120232 study?
This clinical trial studies the following conditions: Anxiety Disorders, Depressive Disorder.
What interventions are being tested in trial NCT05120232?
The interventions under investigation include: Unified Protocol (BEHAVIORAL), Modified Unified Protocol (UP+) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05120232?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05120232 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05120232's enrollment target sits among peer trials
125 37th of 84 higher than 48 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI